Clinical Trials Directory

Trials / Completed

CompletedNCT03729375

The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University of South Florida · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Carpal Tunnel Syndrome patients undergoing carpal tunnel release surgery performed by the PI will receive intra-operative injections of bupivacaine (Marcaine). Two groups of patients will be randomly selected and will receive either 10cc or 20cc of injection. Their post-operative pain scores and usage of post-operative pain medication will be recorded and analyzed.

Detailed description

This randomized control trial will be conducted at the USF Department of Orthopaedics at the USF Health Morsani Center after receiving approval from the USF Institutional Review Board. Patients will be evaluated Carpal Tunnel Syndrome and screened as candidates for Carpal Tunnel Release surgery, following the inclusion and exclusion criteria. The Medical Record Number (MRN) will be used to randomly assign into treatment interventions. Group 1 and group 2 will receive 10cc and 20cc of intra-operative intra-carpal tunnel anesthetic injection, respectively. Postoperatively, patients will be prescribed an opioid pain medication in congruence with current standard medical practice. Patients will be contacted at 24-hours, 48-hours, 72-hours, and at 2-week clinic follow-up by research staff and will be evaluated for pain levels through the LIKERT scale and pain management through use of prescribed and supplemental pain medications. All data will be analyzed through SPSS v25.

Conditions

Interventions

TypeNameDescription
DRUG10cc injection of bupivacaine10cc intra-operative injection of bupivacaine into the carpal tunnel of the operative hand/wrist
DRUG20cc injection of bupivacaine20cc intra-operative injection of bupivacaine into the carpal tunnel of the operative hand/wrist

Timeline

Start date
2018-10-04
Primary completion
2020-10-04
Completion
2020-10-04
First posted
2018-11-02
Last updated
2020-11-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03729375. Inclusion in this directory is not an endorsement.